Literature DB >> 22742517

The Lower Anogenital Squamous Terminology Standardization Project for HPV-Associated Lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology.

Teresa M Darragh1, Terence J Colgan, J Thomas Cox, Debra S Heller, Michael R Henry, Ronald D Luff, Timothy McCalmont, Ritu Nayar, Joel M Palefsky, Mark H Stoler, Edward J Wilkinson, Richard J Zaino, David C Wilbur.   

Abstract

The terminology for human papillomavirus(HPV)–associated squamous lesions of the lower anogenital tract has a long history marked by disparate diagnostic terms derived from multiple specialties. It often does not reflect current knowledge of HPV biology and pathogenesis. A consensus process was convened to recommend terminology unified across lower anogenital sites. The goal was to create a histopathologic nomenclature system that reflects current knowledge of HPV biology, optimally uses available biomarkers, and facilitates clear communication across different medical specialties. The Lower Anogenital Squamous Terminology (LAST) Project was co-sponsored by the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology and included 5 working groups; 3 work groups performed comprehensive literature reviews and developed draft recommendations. Another work group provided the historical background and the fifth will continue to foster implementation of the LAST recommendations. After an open comment period, the draft recommendations were presented at a consensus conference attended by LAST work group members, advisors, and representatives from 35 stakeholder organizations including professional societies and government agencies. Recommendations were finalized and voted on at the consensus meeting. The final, approved recommendations standardize biologically relevant histopathologic terminology for HPV-associated squamous intraepithelial lesions and superficially invasive squamous carcinomas across all lower anogenital tract sites and detail the appropriate use of specific biomarkers to clarify histologic interpretations and enhance diagnostic accuracy. A plan for disseminating and monitoring recommendation implementation in the practicing community was also developed. The implemented recommendations will facilitate communication between pathologists and their clinical colleagues and improve accuracy of histologic diagnosis with the ultimate goal of providing optimal patient care.

Entities:  

Mesh:

Year:  2012        PMID: 22742517     DOI: 10.5858/arpa.LGT200570

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  115 in total

1.  Human papillomavirus genotype-specific prevalence across the continuum of cervical neoplasia and cancer.

Authors:  Nancy E Joste; Brigitte M Ronnett; William C Hunt; Amanda Pearse; Erika Langsfeld; Thomas Leete; MaryAnn Jaramillo; Mark H Stoler; Philip E Castle; Cosette M Wheeler
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-11-02       Impact factor: 4.254

Review 2.  Anal Intraepithelial Neoplasia from a Pathologists Point of View.

Authors:  Keegan M Lyons; Samantha L Butler
Journal:  Clin Colon Rectal Surg       Date:  2018-11-02

Review 3.  Multidisciplinary Approach to the Management and Treatment of Anal Dysplasia.

Authors:  Jeffrey Douaiher; Sean J Langenfeld
Journal:  Clin Colon Rectal Surg       Date:  2018-11-02

4.  Early detection of high-grade squamous intraepithelial lesions in the cervix with quantitative spectroscopic imaging.

Authors:  Condon Lau; Jelena Mirkovic; Chung-Chieh Yu; Geoff P O'Donoghue; Luis Galindo; Ramachandra Dasari; Antonio de las Morenas; Michael Feld; Elizabeth Stier
Journal:  J Biomed Opt       Date:  2013-07       Impact factor: 3.170

5.  [The new S3 guideline "Prevention of cervical carcinoma" : What is important for pathology?]

Authors:  D Schmidt
Journal:  Pathologe       Date:  2018-05       Impact factor: 1.011

Review 6.  Human Papillomavirus Laboratory Testing: the Changing Paradigm.

Authors:  Eileen M Burd
Journal:  Clin Microbiol Rev       Date:  2016-04       Impact factor: 26.132

7.  Sexually transmitted diseases treatment guidelines, 2015.

Authors:  Kimberly A Workowski; Gail A Bolan
Journal:  MMWR Recomm Rep       Date:  2015-06-05

8.  Risk of Invasive Anal Cancer in HIV-Infected Patients With High-Grade Anal Dysplasia: A Population-Based Cohort Study.

Authors:  Yotam Arens; Michael Gaisa; Stephen E Goldstone; Yuxin Liu; Juan Wisnivesky; Carlie S Sigel; Talia H Swartz; Keith Sigel
Journal:  Dis Colon Rectum       Date:  2019-08       Impact factor: 4.585

9.  Classifying Anal Intraepithelial Neoplasia 2 Based on LAST Recommendations.

Authors:  Yuxin Liu; W Glenn McCluggage; Teresa M Darragh; Wenxin Zheng; Jennifer M Roberts; Kay J Park; Pei Hui; Morgan Blakely; Keith Sigel; Michael M Gaisa
Journal:  Am J Clin Pathol       Date:  2021-05-18       Impact factor: 2.493

Review 10.  HPV and anal cancer in HIV-infected individuals: a review.

Authors:  Maarten F Schim van der Loeff; Sofie H Mooij; Oliver Richel; Henry J C de Vries; Jan M Prins
Journal:  Curr HIV/AIDS Rep       Date:  2014-09       Impact factor: 5.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.